Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70.5M | $71.1M | $67.1M | $81.1M | $97.4M | $102M | $110M | $126M | $135M | $143M |
| Revenue growth | — | 0.8% | -5.5% | 20.8% | 20.1% | 5.1% | 7.4% | 14.4% | 7.2% | 6.4% |
| Gross profit | $44.7M | $43.4M | $39.6M | $46.9M | $58.8M | $58.5M | $60.6M | $63.1M | $70.4M | $80.3M |
| Gross margin | 63.5% | 61.0% | 58.9% | 57.8% | 60.3% | 57.2% | 55.1% | 50.2% | 52.2% | 56.0% |
| Operating income | $974K | -$3.81M | $415K | $3.52M | $8.83M | $2.82M | $1.65M | $4.09M | $6.89M | $11.9M |
| Operating margin | 1.4% | -5.4% | 0.6% | 4.3% | 9.1% | 2.8% | 1.5% | 3.2% | 5.1% | 8.3% |
| Net income | -$222K | -$20.7M | -$1.09M | $1.36M | $17.3M | $1.42M | $18.0K | $872K | $2.35M | $6.63M |
| Net margin | -0.3% | -29.1% | -1.6% | 1.7% | 17.8% | 1.4% | 0.0% | 0.7% | 1.7% | 4.6% |
| EPS (diluted) | -$0.01 | -$0.91 | -$0.05 | $0.07 | $0.80 | $0.06 | $0.00 | $0.04 | $0.11 | $0.31 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.91M | $7.72M | $11.4M | $13.9M | $20.3M | $18.3M | $17.5M | $11.2M | $20.5M | $24.4M |
| Capital expenditures | $168K | $104K | $281K | $2.93M | $1.09M | $980K | $982K | $1.02M | $1.09M | $560K |
| Free cash flow | $7.74M | $7.61M | $11.1M | $10.9M | $19.2M | $17.3M | $16.5M | $10.2M | $19.4M | $23.8M |
| Share buybacks | $75.0K | — | $10.4M | $0.00 | $0.00 | $560K | $5.46M | $153K | $1.18M | $9.87M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $3.40M | $3.47M | $4.32M | $2.65M | $9.65M | $186K | $165K | $231K | $527K | $3.19M |
| Total assets | $96.3M | $68.9M | $64.1M | $79.2M | $97.0M | $97.6M | $99.4M | $103M | $104M | $101M |
| Total liabilities | $45.7M | $37.9M | $43.6M | $56.9M | $56.2M | $49.3M | $51.4M | $50.6M | $46.1M | $43.2M |
| Long-term debt | $26.6M | $25.4M | $28.8M | $30.3M | $29.4M | $32.7M | $33.2M | $29.1M | $23.9M | $19.6M |
| Shareholders' equity | $50.7M | $31.0M | $20.4M | $22.3M | $40.8M | $48.3M | $48.0M | $52.3M | $57.5M | $57.3M |
| Retained earnings | -$41.1M | -$61.6M | -$62.7M | -$61.4M | -$44.0M | -$53.9M | -$59.3M | -$58.6M | -$57.5M | -$60.7M |
| Shares (wtd avg diluted) | 22.6M | 22.7M | 21.4M | 20.8M | 21.7M | 22.0M | 21.5M | 21.6M | 21.7M | 21.1M |
Every figure is extracted from InfuSystem Holdings, Inc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.